# MYDAYIS
> **NDA022063** · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2017-06-20
## Drug
- **FDA Application Number:** NDA022063
- **Application type:** New Drug Application
- **Brand name:** MYDAYIS
- **Generic name:** DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE
- **Active ingredients:** AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TAKEDA PHARMS USA
- **Manufacturer:** Takeda Pharmaceuticals America, Inc.
- **First approval:** 2017-06-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022063)
---
*AI Analytics · CC0 1.0*